Protein Production, Drug Discovery, Cell Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
14
NCT03608618
Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 27, 2018
Completion: Aug 24, 2021
Loading map...